Sava look bullish to you

Cassava Sciences (SAVA) exhibits bullish signals, considering the following points:

1. Recent Price Performance: The stock has shown a positive percentage change of 3.37% on September 12, 2024, with a closing price of $28.25. This uptick suggests a recent bullish sentiment among investors.

2. Technical Levels: The support level for SAVA is at $26.8, and the resistance level is at $27.76. The stock is trading close to the resistance level, indicating a potential breakout if the price surpasses this point.

3. Market Sentiment: Despite past losses, there is optimism about SAVA's future profitability. Analysts predict the company will breakeven in 2024, with a significant growth rate of 158% required. This growth expectation could be contributing to the bullish sentiment.
4. Investor Confidence: Big-money investors have taken a bullish stance on SAVA, with a split sentiment among institutions and individuals. This indicates that some investors see potential in the stock, even if there is also caution.
5. Stock Movement Insights: The options activity shows a balanced sentiment, with a slight edge towards bullish calls. This could reflect market anticipation of positive developments or a reaction to recent positive news.
6. Company Developments: The appointment of Richard Barry as permanent CEO, who has been serving as interim CEO since July, is a positive sign for the company's stability and continuity. This change at the helm could be viewed as a bullish signal by the market.

In conclusion, while there are some concerns regarding SAVA's past losses and the efficacy of its Alzheimer's drug, the bullish signals in recent price performance, market sentiment, and company leadership changes suggest a positive outlook for SAVA in the short term.